Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
Semaglutide targets GLP-1 only, which is already powerful for appetite, fullness, digestion, and blood sugar regulation
The Mediterranean dietrich in anti-inflammatory nutrients, fiber, and antioxidantshas been associated with decreased pain and improved quality of life
(2025, March 02)
Schmelzer, C
Concierge Approach To customize and maximize your treatments, our staff includes Physician Assistants, Registered Nurses, and Nurse Practitioners who have over 150 combined years of experience in aesthetics, as well as 2 licensed aestheticians with over 15 combined years of experience in aesthetics